ARC Clinical Research contributes to COVID-19 Vaccine Trial

ARC will recruit 250 ARC patients from across Central Texas to enroll in this late phase clinical trial, intended to prove the safety and efficacy of the sponsor’s vaccine compound and potentially enable this sponsor to be the first to bring a vaccine to market. 

Dr. Gretchen Crook, Principal Investigator for ARC Clinical Research, noted “It is the top priority of the United States and the world to find a successful vaccine to prevent the infection and spread of COVID-19.  This vaccine candidate has the potential to save lives and allow us to return to a way of life that will restore our economy, re-connect our friendships, and continue activities we all enjoy.  ARC Clinical Research was selected as a partner in this study based on our long track record of conducting high quality trials and our speed in enrolling study participants.”

Be a part of history

“This study offers an opportunity to be a part of history and benefit humankind.  There are 7 billion people in our world who will need access to a vaccine to prevent COVID-19 infection, and ARC Clinical Research is thrilled to have a role in bringing a vaccine to Americans”, says Jeff Repper, Director of ARC Clinical Research.

“This is not injecting the virus itself or a piece of the virus. This is studying the RNA of the virus and reproducing it and introducing that in a vaccine so our immune system can recognize it and think it’s the virus, react to it and form immunity to it,” said Dr. Anas Daghestani, CEO of ARC, during an interview with KXAN-TV.

Participants will be compensated for their time and contributions to the clinical study. All COVID-19 vaccine clinical trial services will be delivered at ARC Clinical Research Wilson Parke, located at 11714 Wilson Parke Ave., Suite 150 in Austin’s Four Points neighborhood. 

ARC Clinical Research is a division of Austin Regional Clinic, a physician-owned multispecialty medical group with 350 physicians and clinicians committed to providing comprehensive healthcare services throughout the greater Austin area. 

To start the enrollment process for the COVID-19 vaccine study, please go to ARCclinicalresearch.com and click the orange [Request to Participate] button or call 512-225-5931.

Strict Coronavirus safety measures for care and research trials

In response to COVID-19, ARC has implemented strict safety measures at all clinics and research facilities to ensure that our patients, staff, and physicians remain safe. 

Everyone is screened before entering our clinics, sick and well patients wait in separate spaces with symptomatic patients most often waiting in cars, exam rooms are cleaned and disinfected after each visit, and ARC remains fully stocked with personal protective equipment (PPE). ARC ensures a safe environment to care for all patients and conduct clinical trials. ARC currently participates in seven other research studies at four ARC Clinical Research facilities.

To date, the Centers for Disease Control and Prevention (CDC) has reported almost 5 million COVID-19 cases and over 157,000 deaths in the US while the World Health Organization (WHO) reports more than 700,000 deaths worldwide due to the COVID-19 pandemic.

Dr. Gretchen L. Crook, Principal Investigator - Background

Gretchen L. Crook, MD, joined Austin Regional Clinic in 2002. She joined ARC Clinical Research at the inception in 2017 and stepped into the Lead Physician role in 2019. Under Dr. Crook’s leadership, ARC has participated in over 35 clinical trials and is currently working on 23 studies for such health conditions as lipid management, inflammatory diseases, infectious disease prevention, uterine fibroids, and others. ARC also participates in pediatric studies, including studies in migraines, infant formula, and two meningococcal vaccine studies.

“This is one of many clinical trials currently being conducted by ARC to look at new ways to prevent, detect, or treat diseases that may benefit patients in Central Texas. We are particularly excited to be part of a vaccine trial can literally change the world.”

Dr. Crook, a Family Doctor for almost 20 years, earned her medical degree at the University of Florida College of Medicine before her residency at University of Florida Family Practice Residency Program.  In addition to Principal Investigator, Dr. Crook serves as a Same-Day Care doctor for ARC.  Dr. Crook is a member of the American Academy of Family Physicians and the Travis County Medical Society. She lives in Austin, TX with her family.

ARC Clinical Research Overview

ARC Clinical Research is a network of research clinics that works in partnership with sponsors, typically pharmaceutical, immunotherapy, or medical device companies, to execute clinical studies. In determining which studies to participate in, ARC focuses on those that will most benefit the Central Texas community and looks to participate in clinical research programs that look at new ways to prevent, detect, and treat diseases. The focus is on adult and pediatric clinical studies for preventive, diagnostic, and therapeutic purposes.  With four research offices in and around Austin, ARC Clinical Research offers clinical research opportunities to the Central Texas area.

For more information, visit ARCclinicalresearch.com.

Austin Regional Clinic Overview

Austin Regional Clinic is a multispecialty medical group committed to providing comprehensive healthcare services throughout the greater Austin area.  Founded by three physicians in 1980, it now provides health care to over 530,000 area residents in 28 locations in 12 Central Texas cities, with 19 specialties in primary and specialty care. ARC is unique to the Austin area because of its widespread locations, convenient services and quality assurance programs.

ARC patients enjoy access to such conveniences as:

  • Same-Day and After Hours Appointments
  • 24/7 Phone Nurse and Phone & Online Scheduling
  • ARC MyChart: Online Access to Test Results and Care Team
  • On-site Lab Services
  • On-site or Nearby Radiology Services
  • Clinical Research Trials

For more information, visit AustinRegionalClinic.com.

Tags: ARC Clinical Research, ARC COVID-19 Care, COVID-19 Vaccine

More on this Topic

Texas, including Austin, is leading the way in COVID-19 research

Texas has emerged as a leading site for COVID-19 research, both in the search for a vaccine and for treatments for active cases. ARC Clinical research, part of this trend, has been running a COVID-19 vaccine clinical trial since early August.

ARC COVID-19 vaccine trial to continue on schedule

In response to announcements of the possible release of a COVID-19 vaccine as early as October 2020, ARC has said it will continue its vaccine trial. Dr. Anas Daghestani, CEO of ARC has said, “Our timeline is still the same.”

ARC Teams with Austin-based ENTvantage Diagnostics Dx for New Clinical Trial

ARC’s newest clinical trial tests a device that could help curb antibiotic overuse, "one of the most urgent threats to the public’s health,” according to the Centers for Disease Control (CDC).

ARC Begins Clinical Trials for First-of-its-Kind Device for Antibiotic Overuse

If you live in Central Texas, commonly referred to as an “allergy capital”, chances are you or a family member have suffered a sinus infection, also known as sinusitis. And chances are, if you have had sinusitis, an antibiotic has been prescribed. Yet, according to public health experts, the vast majority of sinusitis cases are not helped by antibiotics.

ARC Clinical Research Featured in Community Impact

ARC Clinical Research, based at ARC Wilson Parke, is featured in an article in Community Impact’s Lake Travis/Westlake edition. The article explains ARC’s involvement in a global study for a new antiviral flu drug, Xofluza, that may be available as early as 2019.